Moreover, two original studies combining T-tau and P-tau values showed very good diagnostic performance when comparing CJD and AD patients, with a sensitivity of 91–100% and specificity of 97–100% (Buerger et al., 2006; Matsui et al., 2010). This evidence concerns the gene MAPT and Creutzfeldt Jacob disease.